Elías Campo Güerri

Head of Section

Hospital Clínic – Biomedical Diagnostic Center – Pathology

Recent articles

• POT1 mutations cause telomere dysfunction in chronic lymphocytic leukaemia.
  Ramsay AJ, Quesada V, Foronda M, Conde L, Martínez-Trillos A, Villamor N, Rodríguez D, Kwarciak A, Garabaya C, Gallardo M, López-Guerra M, López-Guillermo A, Puente XS, Blasco MA, Campo E, López-Otín C..
  Nature Genetics. 2013;45:526-530
• SOX11 regulates PAX5expression and blocks terminal B-cell differentiation in aggressive mantle celllymphoma.
  Vegliante MC, Palomero J, Pérez-Galán P, Roué G, Castellano G, Navarro A, ClotG, Moros A, Suárez-Cisneros H, Beà S, Hernández L, Enjuanes A, Jares P, Villamor N, Colomer D, Martín-Subero JI, Campo E, Amador V. .
  Blood. 2013;121:2175-2185
• Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biological and clinical features
  Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, Bikos V, Darzentas N, Papadaki T, Salaverria I, Pinyol M, Puig X, Palomero J, Vegliante MC, Amador V, Martinez-Trillos A, Stefancikova L, Wiestner A, Wilson W, Pott C, Calasanz M, Trim N, Erber W, Sander B, Ott G, Rosenwald A, Colomer D, Giné E, Siebert R, López-Guillermo A, Stamatopoulos K, Beà S, Campo E. .
  Cancer Res. 2012;72:5307-5316
• Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
  Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G, Martínez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, Barberán-Soler S, Papasaikas P, Jares P, Beà S, Rico D, Ecker S, Rubio M, Royo R, Ho V, Klotzle B, Hernández L, Conde L, López-Guerra M, Colomer D, Villamor N, Aymerich M, Rozman M, Bayes M, Gut M, Gelpí JL, Orozco M, Fan JB, Quesada V, Puente XS, Pisano DG, Valencia A, López-Guillermo A, Gut I, López-Otín C, Campo E, Martín-Subero JI. .
  Nature. 2012;44:1236-1242
• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.
  Quesada V, Conde L, Villamor N, Ordóñez GR, Jares P, Bassaganyas L, Ramsay AJ,Beà S, Pinyol M, Martínez-Trillos A, López-Guerra M, Colomer D, Navarro A, Baumann T, Aymerich M, Rozman M, Delgado J, Giné E, Hernández JM, González-Díaz, M, Puente DA, Velasco G, Freije JM, Tubío JM, Royo R, Gelpí JL, Orozco M, Pisano DG, Zamora J, Vázquez M, Valencia A, Himmelbauer H, Bayés M, Heath S, Gut M, Gut I, Estivill X, López-Guillermo A, Puente XS, Campo E*, López-Otín C*. .
  Nature Genetics . 2011;44:47-52

Academic Qualifications

• DOCTOR IN MEDICINE AND SURGERY – FACULTY OF MEDICINE (1985)
• SPECIALIST DOCTOR IN PATHOLOGIC ANATOMY – HOSPITAL PRÍNCIPES DE ESPAÑA (1984)
• MEDICINE AND SURGERY DEGREES – UNIVERSITY OF BARCELONA (1979)